GlassScriptPhysician profile
Michael J Wasserman
NPI 1326004938
$15,197.34
in general payments reported to CMS, 2019-2025
52 companies · $689 in 2025
The $689 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,137 · 2020: $2,657 · 2021: $2,529 · 2022: $4,592 · 2023: $1,302 · 2024: $1,291 · 2025: $689.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,281.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,494.53 | 2019-2025 | Duopa, Ubrelvy |
| Ucb, INC. | $1,513.40 | 2019-2024 | Rystiggo, Briviact |
| Teva Pharmaceuticals USA, INC. | $854.31 | 2019-2025 | Austedo Xr |
| Neurocrine Biosciences, INC. | $825.74 | 2019-2025 | Ingrezza, Ongentys |
| Lilly USA, LLC | $598.40 | 2019-2025 | Emgality, Kisunla, Amyvid |
| Biogen, INC. | $577.00 | 2019-2025 | Vumerity, Tysabri |
| Genzyme Corporation | $572.22 | 2019-2023 | |
| Sunovion Pharmaceuticals INC. | $543.91 | 2020-2022 | |
| Emd Serono, INC. | $476.12 | 2019-2022 | |
| Eisai INC. | $455.84 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $405.64 | 2019-2024 | Ultomiris, Soliris |
| Mdd US Operations, LLC | $368.41 | 2019-2025 | Gocovri, Xadago, Myobloc |
| Novartis Pharmaceuticals Corporation | $283.56 | 2019-2022 | |
| Amgen INC. | $262.36 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $247.19 | 2020-2022 |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Wasserman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.